vimarsana.com

Page 7 - உலகளாவிய ஆரோக்கியம் கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Remembering Tania Douglas: a brilliant biomedical engineer, academic and friend

Tributes from friends, colleagues, collaborators and students have poured in for South African academic Professor Tania Samantha Douglas, an internationally recognised scholar, biomedical engineer and innovator. She passed away on 20 March 2021. She was admired by many and consulted broadly for her unique insights, in-depth understanding of South Africa’s higher education environment, and open-mindedness. Always vibrant, she was able to fully engage with issues in an unbiased manner – sharing her well-considered thoughts in a friendly and practical way. Tania obtained the second highest grade in the country in her final school exams in 1987. She went on to read for a BScEng in Electrical and Electronic Engineering at the University of Cape Town (UCT). This was followed by an MS in Biomedical Engineering at Vanderbilt University in Nashville, Tennessee. Then came a PhD in Bioengineering from the University of Strathclyde in Glasgow, and a postdoctoral fellowship in image proces

America helps itself by vaccinating the world

True win-win propositions are rare. America paying to vaccinate the world against the coronavirus is one of them. Joe Biden's plan to buy and donate 500 million doses of Pfizer’s jab to poor and middle-income countries is a cheap way to spread goodwill. It’s also in the nation's economic self-interest. Going further and finishing the job could cost under $40 billion.

Anxieties about side-effects and perceived trial uncertainties driving vaccine hesitancy

 E-Mail Concerns about side effects and whether vaccines have been through enough testing are holding people back from getting vaccinated against COVID-19, according to a new report. Data from an international survey of 15 countries which ran between March and May this year showed that these were the most commonly cited reasons for not having had a coronavirus vaccine yet, in addition to not being eligible for one. Respondents other commonly reported reasons included concerns about not getting the vaccine they would prefer, and worries over whether the vaccines are effective enough. Led by Imperial College London s Institute of Global Health Innovation in collaboration with YouGov, the survey also looked at trust in COVID-19 vaccines. Findings from over 68,000 people showed that there is variation across the world but overall, confidence is high with greater than 50% of respondents saying they trust coronavirus vaccines, except in South Korea and Japan (47%). People in the UK

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.